Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
Cytology sample slide with AI brain overlay

May 30, 2026

IDEXX Laboratories Touts AI Push, inVue Dx Momentum at Stifel Conference

IDEXX Laboratories has recently highlighted its advancements in artificial intelligence and software within veterinary diagnostics during a Stifel investor conference. CEO Michael Erickson emphasized the company's commitment to innovation and its strategy aimed at enhancing diagnostic capabilities and practice efficiency for veterinarians.Erickson pointed out that IDEXX is integrating AI into its diagnostic platforms, citing inVue Dx as a prime example. This platform streamlines cytology workflo
A minimalist representation of a molecular structure in a dark color scheme.

May 30, 2026

Why Pharma’s Tech Revolution Must Cure Itself First

The pharmaceutical industry is at a crossroads, facing the dual challenge of technological advancement and the need for a sustainable business model.Recent discussions at an international pharmaceutical science conference highlighted the transformative changes driven by artificial intelligence (AI) in drug development. AI is now integral to the creation of new molecules, significantly reducing the timeline for drug discovery from four years to just 18 months. This technological leap promises not
A desk with regulatory documents and a medical device in a dimly lit office.

May 30, 2026

Tata Elxsi and OpenAna Unveil Anatel™, An AI‑Native Platform Redefining Regulatory‑Ready MedTech Software Engineering

Tata Elxsi and OpenAna have introduced AnaTel™, an innovative AI-native platform aimed at transforming regulatory-ready software engineering in the MedTech sector.This platform was unveiled at DeviceTalks Boston 2026 and is designed to streamline compliance processes while significantly reducing the development timelines for Software as a Medical Device (SaMD). By leveraging autonomous AI agents, AnaTel™ can cut development cycles from eight weeks to just 72 hours, potentially increasing product
A handful of euro coins on a rustic wooden table in a café

May 30, 2026

EU-Startups Weekly Funding Round-Up: May 25 – May 29

The latest funding round-up from EU-Startups reveals a thriving European startup ecosystem, particularly in healthtech and technology sectors.This week, significant investments were reported across Europe, demonstrating the robust interest from venture capitalists in various industries. Notably, Dublin's Fonoa, an AI TaxTech startup, raised €94.4 million in Series C funding, which will be used to enhance its offerings following the acquisition of PwC's tax platform. This move underscores the inc
A surgical instrument on a stainless steel table in a clinical workspace.

May 30, 2026

YEIDA Signs MoU with Medical Excellence Japan to Boost Medtech Collaboration

The Uttar Pradesh Government has formalized a memorandum of understanding (MoU) with Medical Excellence Japan (MEJ) to enhance collaboration in the medical devices sector.This partnership, facilitated by the Yamuna Expressway Industrial Development Authority (YEIDA), aims to bolster research and development (R&D) capabilities, promote technology transfer, and attract investment for the forthcoming YEIDA Medical Device Park. Key figures in this agreement include YEIDA CEO Rakesh Kumar Singh and M
A hand holding a medical chart in a clinical setting

May 30, 2026

Millions to benefit from Sci Tech deal between UK and France

A new partnership between the UK and France aims to enhance research in women’s health and infectious diseases, utilizing advanced AI and supercomputing technologies.This collaboration will leverage the capabilities of two leading European supercomputers to accelerate scientific discovery and improve healthcare outcomes. Specifically, the initiative targets under-researched areas such as childbirth complications and endometriosis, aiming to deliver earlier diagnoses and more personalized care fo
An open research notebook with a pen in a dimly lit office setting.

May 30, 2026

Simplification, standardisation & AI-enabled industry: Veeva R&D and Quality Summit 2026

The Veeva R&D and Quality Summit 2026 in Copenhagen focused on advancing the life sciences industry through standardization and AI integration.This year's summit, held on May 28-29, emphasized the vision of creating a unified industry cloud aimed at improving patient outcomes. Veeva, a leader in providing cloud solutions for life sciences, serves a diverse clientele, including major pharmaceutical firms and emerging biotech companies. Senior VP Rik Van Mol highlighted the importance of collabora
A minimalist illustration of a bridge representing collaboration in biotechnology.

May 30, 2026

Turning Malaysia into a bridge for China’s biotech ambitions

BioNexus Gene Lab Corp. is advocating for enhanced cooperation between Malaysia and China in the biotechnology sector, emphasizing a shift from mere trade to collaborative development. This initiative was highlighted during the recent China–Malaysia Economic Cooperation Outlook Forum, where industry leaders convened to explore strategic partnerships.At the forum, BioNexus CEO Sam Tan underscored the potential for establishing a precision healthcare corridor that focuses on co-development and cli
Specimen slide on a lab bench with a microscope in the background

May 30, 2026

TEM: AI-powered diagnostics and data platform targets $2.5B+ revenue by 2028 with accelerating growth

A recent report highlights the significant growth trajectory of an AI-driven diagnostics and data platform, projecting substantial revenue increases by 2028. The platform has experienced a remarkable 28% increase in volume during the first quarter of 2026, indicating robust expansion in both its diagnostics and data segments. By 2028, revenue is anticipated to reach approximately $1.9 billion in diagnostics and $650 million in data services. Furthermore, the company expects to achieve profitabil
Stylized upward arrow symbolizing stock growth

May 30, 2026

Tempus AI Stock Climbs As Pharma, Alzheimer’s Deals Build Momentum

Tempus AI Inc. has seen a significant stock increase of 7.95%, driven by positive coverage of its AI healthcare data platform.Tempus AI (NASDAQ: TEM) has recently experienced notable momentum, climbing from the mid-$40s to over $51, with peaks above $56 earlier this month. The company reported trailing revenues of approximately $1.27 billion and anticipates growth to $1.2 billion in 2025 and $1.59 billion in 2026. Despite current negative margins, the company's adjusted EBITDA is projected to tu
A stack of financial reports and a calculator on an office desk

May 30, 2026

AI is Everywhere in Life Sciences Revenue Management. So, Why Is $50 Billion Still Leaking?

Despite the high adoption of AI in life sciences revenue management, companies are still losing over $50 billion annually due to systemic inefficiencies.According to Model N’s 2026 State of Revenue Report, an impressive 97% of life sciences organizations are currently utilizing AI for revenue management, with projections indicating this will rise to over 99% in the next two years. However, the report reveals a paradox: while these companies are heavily investing in AI, they continue to grapple w
A test tube with a blood sample in a clinical lab setting

May 30, 2026

Deloitte 2026 Diagnostics Report: Scaling AI and Interoperability inside Consumer-Driven Workflows

The Deloitte Center for Health Solutions' latest survey reveals that a significant majority of diagnostics manufacturers recognize the need to adapt to a B2B2C operational model to drive future growth, with 62% of executives highlighting this shift as crucial.This transformation is underscored by a growing disconnect between manufacturers and healthcare providers. While providers identify test ordering as their primary challenge, manufacturers mistakenly focus on results interpretation. The cons